focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picks3i Group Regulatory News (III)

Share Price Information for 3i Group (III)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,958.00
Bid: 2,957.00
Ask: 2,958.00
Change: -19.00 (-0.64%)
Spread: 1.00 (0.034%)
Open: 2,964.00
High: 2,967.00
Low: 2,936.00
Prev. Close: 2,977.00
III Live PriceLast checked at -
3i Group is an Investment Trust

To provide its shareholders with quoted access to private equity and infrastructure returns, its main focus is on making quoted and unquoted equity and/ or debt investments in businesses and funds in Europe, Asia and the Americas.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

13 Jun 2014 15:24

RNS Number : 6264J
3i Group PLC
13 June 2014
 



13 June 2014

3i Group plc

Repurchase and cancellation of B Shares

On 14 May 2014, 3i Group plc (the "Company") announced that the Company had made arrangements with Merrill Lynch International ("MLI") for MLI to offer to purchase all the issued B Shares for cash at a price of 131.4364 pence per B Share.

Following MLI's acquisition of the B Shares under the terms announced on 14 May 2014, MLI has today exercised its right to require the Company to purchase from MLI all the B Shares and the Company has consequently repurchased all 4,635,018 B Shares from MLI for 131.4364 pence per B Share. The Company confirms that all the B Shares will be cancelled and not held as treasury shares.

 

Following the cancellation of the B Shares, which is expected to be effective on 17 June 2014, no B Shares will remain in issue. The Company will then request the listing cancellation of the B Shares which is expected to occur on or shortly after 18 June 2014.

 For further information, contact:

Kathryn van der Kroft, Communications Director

Tel: +44 20 7975 3021

Silvia Santoro, Investor Relations Director

Tel: +44 20 7975 3258

 

Notes to editors:

1. 3i is a leading international investor focused on mid-market private equity, infrastructure and debt management. For further information please refer to www.3i.com.

2. The Company issued B Shares in 2006 and 2007 as part of arrangements to return value to shareholders. A number of offers to purchase these B Shares were made in 2006 to 2009 which gave shareholders flexibility as to when they received the proceeds of the return of value and, in certain cases, as to whether the proceeds represented income or capital. The terms of issue of the B Shares allowed the Company to arrange for all outstanding B Shares to be purchased at any time after July 2009 and it was always intended that this would be done at an appropriate time. On 14 May 2014 the Company announced that arrangements had been made for such a purchase of all outstanding B shares.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
POSZMGMVDFGGDZM
Date   Source Headline
30th Jun 20202:08 pmRNSDirector/PDMR Shareholding
26th Jun 20205:03 pmRNSDirector/PDMR Shareholding
25th Jun 20204:12 pmRNSDirector/PDMR Shareholding
25th Jun 202012:55 pmRNSResult of AGM
25th Jun 202012:54 pmRNSDoc re. AGM Resolutions
18th Jun 20209:00 amRNSDirector/PDMR Shareholding
11th Jun 202010:39 amRNSBlock listing Interim Review
10th Jun 20202:52 pmRNSDirector/PDMR Shareholding
3rd Jun 20201:30 pmRNSDirector/PDMR Shareholding
3rd Jun 202012:00 pmRNSPublication of a Prospectus
29th May 20204:03 pmRNSTotal Voting Rights
29th May 20204:02 pmRNSDirector/PDMR Shareholding
29th May 202010:37 amRNSDTR 6.3.5
27th May 202011:04 amRNSDoc re. 2020 Notice of AGM
20th May 202010:55 amRNSDoc re. 2020 Annual Report and Accounts
14th May 20207:00 amRNSResults for the year to 31 March 2020
30th Apr 20203:09 pmRNSTotal Voting Rights
30th Apr 20203:08 pmRNSDirector/PDMR Shareholding
1st Apr 202010:02 amRNSDirector/PDMR Shareholding
30th Mar 20209:39 amRNSDirector/PDMR Shareholding
30th Mar 20209:38 amRNSDirector/PDMR Shareholding
19th Mar 20208:30 amRNSCovid-19 update and Action Seminar
10th Mar 20202:28 pmRNSHolding(s) in Company
28th Feb 20204:10 pmRNSTotal Voting Rights
28th Feb 20204:07 pmRNSDirector/PDMR Shareholding
20th Feb 202011:30 amRNSHolding(s) in Company
4th Feb 20203:56 pmRNSHolding(s) in Company
31st Jan 20204:18 pmRNSTotal Voting Rights
31st Jan 20204:15 pmRNSDirector/PDMR Shareholding
30th Jan 20207:00 amRNSFY2020 Q3 Performance update
7th Jan 202011:51 amRNSPortfolio Update
3rd Jan 20203:18 pmRNSTotal Voting Rights
3rd Jan 20203:15 pmRNSDirector/PDMR Shareholding
2nd Jan 202011:47 amRNSDirectorate Change
17th Dec 20194:02 pmRNSDirector/PDMR Shareholding
11th Dec 201910:48 amRNSBlock listing Interim Review
3rd Dec 201912:00 pmRNSDirector/PDMR Shareholding
29th Nov 20193:17 pmRNSTotal Voting Rights
29th Nov 20193:13 pmRNSDirector/PDMR Shareholding
14th Nov 20191:39 pmRNSDoc re. Half Yearly Report 2019
14th Nov 20197:00 amRNSHalf-year Report
31st Oct 20192:52 pmRNSTotal Voting Rights
31st Oct 20192:51 pmRNSDirector/PDMR Shareholding
1st Oct 20193:44 pmRNSPortfolio Update
30th Sep 20193:01 pmRNSTotal Voting Rights
30th Sep 20192:52 pmRNSDirector/PDMR Shareholding
23rd Sep 201911:55 amRNSDirector/PDMR Shareholding
18th Sep 20199:00 amRNSPrivate Equity Capital Markets Seminar
2nd Sep 201912:12 pmRNSDirector Declaration
30th Aug 20193:37 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.